GARMIN LTD

GRMN

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Eventide Asset Management

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Eventide Asset ManagementNEWFeb 13, 2026

Shares: 69,476Value: $14.1M

**Signal Note:** This position initiation appears incongruent with Eventide's biotech-focused mandate, as Garmin is a consumer electronics/GPS navigation company with no pharmaceutical pipeline or healthcare operations. The $14.1M allocation likely reflects either a portfolio rebalancing decision, ESG/values-based criteria alignment (manufacturing practices, supply chain), or potential data management applications in healthcare—though the lack of disclosed biotech rationale warrants clarification from the fund on investment thesis.

More GRMN Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

CPRT1 fund DECK1 fund LITE1 fund NTAP1 fund GPI1 fund IMMX1 fund PI1 fund UNP1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: